162 related articles for article (PubMed ID: 32911191)
61. Flurbiprofen derivatives as novel α-amylase inhibitors: Biology-oriented drug synthesis (BIODS), in vitro, and in silico evaluation.
Khan M; Alam A; Khan KM; Salar U; Chigurupati S; Wadood A; Ali F; Mohammad JI; Riaz M; Perveen S
Bioorg Chem; 2018 Dec; 81():157-167. PubMed ID: 30125730
[TBL] [Abstract][Full Text] [Related]
62. Synthesis, biological evaluation, and docking studies of novel 5,6-diaryl-1,2,4-triazine thiazole derivatives as a new class of α-glucosidase inhibitors.
Wang G; Peng Z; Gong Z; Li Y
Bioorg Chem; 2018 Aug; 78():195-200. PubMed ID: 29587132
[TBL] [Abstract][Full Text] [Related]
63. Synthesis and biological evaluation of novel 2,4,5-triarylimidazole-1,2,3-triazole derivatives via click chemistry as α-glucosidase inhibitors.
Wang G; Peng Z; Wang J; Li J; Li X
Bioorg Med Chem Lett; 2016 Dec; 26(23):5719-5723. PubMed ID: 27810241
[TBL] [Abstract][Full Text] [Related]
64. Synthesis, molecular docking and comparative efficacy of various alkyl/aryl thioureas as antibacterial, antifungal and α-amylase inhibitors.
Larik FA; Saeed A; Faisal M; Channar PA; Azam SS; Ismail H; Dilshad E; Mirza B
Comput Biol Chem; 2018 Dec; 77():193-198. PubMed ID: 30340081
[TBL] [Abstract][Full Text] [Related]
65. Synthesis, Biological Evaluation and Molecular Docking Study of 2-Substituted-4,6-Diarylpyrimidines as α-Glucosidase Inhibitors.
Gong Z; Xie Z; Qiu J; Wang G
Molecules; 2017 Oct; 22(11):. PubMed ID: 29084182
[TBL] [Abstract][Full Text] [Related]
66. A new entry into the portfolio of α-glucosidase inhibitors as potent therapeutics for type 2 diabetes: Design, bioevaluation and one-pot multi-component synthesis of diamine-bridged coumarinyl oxadiazole conjugates.
Kazmi M; Zaib S; Ibrar A; Amjad ST; Shafique Z; Mehsud S; Saeed A; Iqbal J; Khan I
Bioorg Chem; 2018 Apr; 77():190-202. PubMed ID: 29421697
[TBL] [Abstract][Full Text] [Related]
67. Molecular docking studies and synthesis of novel bisbenzimidazole derivatives as inhibitors of α-glucosidase.
Özil M; Emirik M; Beldüz A; Ülker S
Bioorg Med Chem; 2016 Nov; 24(21):5103-5114. PubMed ID: 27576293
[TBL] [Abstract][Full Text] [Related]
68. Synthesis and molecular docking studies of potent α-glucosidase inhibitors based on biscoumarin skeleton.
Khan KM; Rahim F; Wadood A; Kosar N; Taha M; Lalani S; Khan A; Fakhri MI; Junaid M; Rehman W; Khan M; Perveen S; Sajid M; Choudhary MI
Eur J Med Chem; 2014 Jun; 81():245-52. PubMed ID: 24844449
[TBL] [Abstract][Full Text] [Related]
69. Quinazolinone derivatives: Synthesis and comparison of inhibitory mechanisms on α-glucosidase.
Wei M; Chai WM; Wang R; Yang Q; Deng Z; Peng Y
Bioorg Med Chem; 2017 Feb; 25(4):1303-1308. PubMed ID: 28110817
[TBL] [Abstract][Full Text] [Related]
70. In vitro and in silico evaluations of diarylpentanoid series as α-glucosidase inhibitor.
Leong SW; Abas F; Lam KW; Yusoff K
Bioorg Med Chem Lett; 2018 Feb; 28(3):302-309. PubMed ID: 29292226
[TBL] [Abstract][Full Text] [Related]
71. Biscoumarin-1,2,3-triazole hybrids as novel anti-diabetic agents: Design, synthesis, in vitro α-glucosidase inhibition, kinetic, and docking studies.
Asgari MS; Mohammadi-Khanaposhtani M; Kiani M; Ranjbar PR; Zabihi E; Pourbagher R; Rahimi R; Faramarzi MA; Biglar M; Larijani B; Mahdavi M; Hamedifar H; Hajimiri MH
Bioorg Chem; 2019 Nov; 92():103206. PubMed ID: 31445191
[TBL] [Abstract][Full Text] [Related]
72. Design, synthesis and docking study of novel tetracyclic oxindole derivatives as α-glucosidase inhibitors.
Han K; Li Y; Zhang Y; Teng Y; Ma Y; Wang M; Wang R; Xu W; Yao Q; Zhang Y; Qin H; Sun H; Yu P
Bioorg Med Chem Lett; 2015 Apr; 25(7):1471-5. PubMed ID: 25759031
[TBL] [Abstract][Full Text] [Related]
73. In vitro and in silico studies of fluorinated 2,3-disubstituted thiazolidinone-pyrazoles as potential α-amylase inhibitors and antioxidant agents.
Ganavi D; Ramu R; Kumar V; Patil SM; Martiz RM; Shirahatti PS; Sathyanarayana R; Poojary B; Holla BS; Poojary V; Kumari KPN; Shivachandra JC
Arch Pharm (Weinheim); 2022 Mar; 355(3):e2100342. PubMed ID: 34923670
[TBL] [Abstract][Full Text] [Related]
74. Synthesis of oxazolidinone from enantiomerically enriched allylic alcohols and determination of their molecular docking and biologic activities.
Atmaca U; Kaya R; Karaman HS; Çelik M; Gülçin İ
Bioorg Chem; 2019 Jul; 88():102980. PubMed ID: 31174010
[TBL] [Abstract][Full Text] [Related]
75. A simple and efficient synthesis of novel inhibitors of alpha-glucosidase based on benzimidazole skeleton and molecular docking studies.
Özil M; Emirik M; Etlik SY; Ülker S; Kahveci B
Bioorg Chem; 2016 Oct; 68():226-35. PubMed ID: 27572707
[TBL] [Abstract][Full Text] [Related]
76. Synthesis of novel flavonoid alkaloids as α-glucosidase inhibitors.
Zhen J; Dai Y; Villani T; Giurleo D; Simon JE; Wu Q
Bioorg Med Chem; 2017 Oct; 25(20):5355-5364. PubMed ID: 28797772
[TBL] [Abstract][Full Text] [Related]
77. Design, synthesis and α-amylase inhibitory activity of novel chromone derivatives.
Valentina P; Ilango K; Chander S; Murugesan S
Bioorg Chem; 2017 Oct; 74():158-165. PubMed ID: 28802166
[TBL] [Abstract][Full Text] [Related]
78. A new series of Schiff base derivatives bearing 1,2,3-triazole: Design, synthesis, molecular docking, and α-glucosidase inhibition.
Nasli-Esfahani E; Mohammadi-Khanaposhtani M; Rezaei S; Sarrafi Y; Sharafi Z; Samadi N; Faramarzi MA; Bandarian F; Hamedifar H; Larijani B; Hajimiri M; Mahdavi M
Arch Pharm (Weinheim); 2019 Aug; 352(8):e1900034. PubMed ID: 31330079
[TBL] [Abstract][Full Text] [Related]
79. Evaluation of α-glucosidase inhibiting potentials with docking calculations of synthesized arylidene-pyrazolones.
Chaudhry F; Naureen S; Choudhry S; Huma R; Ashraf M; Al-Rashida M; Jahan B; Hyder Khan M; Iqbal F; Ali Munawar M; Ain Khan M
Bioorg Chem; 2018 Apr; 77():507-514. PubMed ID: 29454828
[TBL] [Abstract][Full Text] [Related]
80. Design, synthesis, kinetic mechanism and molecular docking studies of novel 1-pentanoyl-3-arylthioureas as inhibitors of mushroom tyrosinase and free radical scavengers.
Larik FA; Saeed A; Channar PA; Muqadar U; Abbas Q; Hassan M; Seo SY; Bolte M
Eur J Med Chem; 2017 Dec; 141():273-281. PubMed ID: 29040952
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
